Today, Aegis Brands Inc. (TSX: AEG) reports financial results for the second quarter ending June 29th, 2025. Highlights for the quarter: — System sales decreased by 4.2% to $35.2 million and same store sales decreased by 7.5%. — Adjusted EBITDA for the second quarter was consistent with the prior year at $1.6 million. — Net […]
Astute Connect: The Expert Network industry to Reach US$ 5.5 Billion by 2030 Business in today's fast-paced and knowledge-driven world is constantly under pressure to innovate, adapt, and make informed decisions quickly to maintain its competitive edge. Expertise is more important than ever, as specialized knowledge affects business success, problem-solving, and strategic planning. GlobeNewswire August
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases GlobeNewswire August 01, 2025 MOUNTAIN VIEW, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, today issued the following statement in response to the Centers for
Abeona Therapeutics(R) Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 01, 2025 CLEVELAND, Aug. 01, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders Aptose to hold a reconvened shareholder meeting on August 22, 2025 at 10:00 a.m. (Eastern Time) to vote on appointment of new auditor GlobeNewswire August 01, 2025 SAN DIEGO and TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE)
Nexxen Announces July 2025 Share Repurchase Program Summary GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that during July 2025 the Company repurchased 880,000 Ordinary Shares
Notice of Knight Therapeutics' Second Quarter 2025 Results Conference Call GlobeNewswire August 01, 2025 MONTREAL, Aug. 01, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2025 financial results on Thursday, August 7, 2025 prior to market opening. Following the release, Knight will
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 01, 2025 CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on August 1, 2025, it awarded an inducement grant to five new employees
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=159192&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=159191&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or